DNA synthesis is a pivotal aspect of biopharmaceutics, playing a crucial role in the development of advanced therapies and drugs. This intricate process involves the creation of artificial genes or DNA sequences, often customized for therapeutic purposes. The precision of DNA synthesis is paramount, ensuring the accurate replication of genetic material for applications such as gene therapy and the production of biopharmaceuticals.
In the realm of biopharmaceutics, DNA synthesis serves as the foundation for the design and production of recombinant proteins, monoclonal antibodies, and other biologics. This technology enables scientists to engineer specific genetic sequences, tailoring therapeutic agents to target precise molecular pathways. The advancements in DNA synthesis techniques have significantly contributed to the rapid evolution of biopharmaceutical research and development, fostering innovation in precision medicine.
As biopharmaceutics continues to push the boundaries of medical science, DNA synthesis stands at the forefront, driving breakthroughs that hold the promise of more targeted, effective, and personalized therapeutic interventions. The convergence of biotechnology and pharmaceuticals in the realm of DNA synthesis underscores its integral role in shaping the future of healthcare.
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian FederationSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia